Alpha7 neuronal nicotinic receptors: The missing link to understanding Alzheimer's etiopathology?

Medical Hypotheses

Volumn 74, Issue 2, 2010, Pages 281-285

  Bencherif, Merouane ^a   Lippiello, Patrick M ^a  

^a TARGACEPT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; BUNGAROTOXIN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; JANUS KINASE 2; STAT3 PROTEIN; TAU PROTEIN; WNT PROTEIN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; AMYLOIDOSIS; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC RISK; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK REDUCTION; SYNAPTIC INHIBITION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; MODELS, NEUROLOGICAL; RECEPTORS, NICOTINIC;

EID: 72449129007     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.09.011     Document Type: Article

References (36)

1. Morris J.C., and Price A.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17 (2001) 101-118
2. Driscoll I., Resnick S.M., Troncoso J.C., et al. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. Ann Neurol 60 (2006) 688-695
3. Iacono D., Markesbery W.R., Gross M., et al. The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (2009)
4. Wilson R.S., Bienias J.L., Evans D.A., et al. Religious orders study: overview and Changein cognitive and motor speed. Aging Neuropsychol Cognition 11 (2004) 280-303
5. Bennett D.A., Schneider J.A., Buchman A.S., et al. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 25 (2005) 163-175
6. Bennett D.A. Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project. Alzheimer Dis Assoc Disord 20 (2006) S63-S68
7. Gotti C., Moretti M., Gaimarri A., et al. Heterogeneity and complexity of native brain nicotinic receptors. Biochem Pharmacol 74 (2007) 1102-1111
8. Albuquerque E.X., Pereira E.F., Alkondon M., et al. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89 (2009) 73-120
9. Wonnacott S., Barik J., Dickinson J., et al. Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. J Mol Neurosci 30 (2006) 137-140
10. Sharma G., and Vijayaraghavan S. Nicotinic receptors containing the alpha7 subunit: a model for rational drug design. Curr Med Chem 15 (2008) 2921-2932
11. Banerjee C., Nyengaard J.R., Wevers A., et al. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease - a stereological approach. Neurobiol Dis 7 (2000) 666-672
12. Lacor P.N., Buniel M.C., Chang L., et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24 (2004) 10191-10200
13. Marrero M.B., and Bencherif M. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res 1256 (2009) 1-7
14. Bencherif M. Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance. Acta Pharmacol Sin 30 (2009) 702-714
15. Eddins D., Klein R.C., Yakel J.L., et al. Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res Bull 79 (2009) 111-115
16. Bitner R.S., Nikkel A.L., Markosyan S., et al. Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo. Brain Res 1265 (2009) 65-74
17. Farias G.G., Valles A.S., Colombres M., et al. Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons. J Neurosci 27 (2007) 5313-5325
18. Dziewczapolski G., Glogowski C.M., Masliah E., et al. Deletion of the alpha7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J Neurosci 29 (2009) 8805-8815
19. Dineley K.T. Beta-amyloid peptide-nicotinic acetylcholine receptor interaction: the two faces of health and disease. Front Biosci 12 (2007) 5030-5038
20. Liu Q., Zhang J., Zhu H., et al. Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J 21 (2007) 61-73
21. Shaw S., Bencherif M., and Marrero M.B. Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J Biol Chem 277 (2002) 44920-44924
22. Marrero M.B., Papke R.L., Bhatti B.S., et al. The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase. J Pharmacol Exp Ther 309 (2004) 16-27
23. Kihara T., Shimohama S., Sawada H., et al. Alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276 (2001) 13541-13546
24. Hu M., Waring J.F., Gopalakrishnan M., et al. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells. J Neurochem 106 (2008) 1371-1377
25. Bolmont T., Clavaguera F., Meyer-Luehmann M., et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol 171 (2007) 2012-2020
26. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10 (2009) 333-344
27. Gay E.A., Bienstock R.J., Lamb P.W., et al. Structural determinates for apolipoprotein E-derived peptide interaction with the alpha7 nicotinic acetylcholine receptor. Mol Pharmacol 72 (2007) 838-849
28. Klein R.C., and Yakel J.L. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience 127 (2004) 563-567
29. Carson R., Craig D., McGuinness B., et al. Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease. J Med Genet 45 (2008) 244-248
30. Patapoutian A., and Reichardt L.F. Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 10 (2000) 392-399
31. Lie D.C., Colamarino S.A., Song H.J., et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature 437 (2005) 1370-1375
32. Ahmad-Annuar A., Ciani L., Simeonidis I., et al. Signaling across the synapse: a role for Wnt and dishevelled in presynaptic assembly and neurotransmitter release. J Cell Biol 174 (2006) 127-139
33. Garrido J.L., Godoy J.A., Alvarez A., et al. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J 16 (2002) 1982-1984
34. Quintanilla R.A., Munoz F.J., Metcalfe M.J., et al. Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J Biol Chem 280 (2005) 11615-11625
35. Alvarez A.R., Godoy J.A., Mullendorff K., et al. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297 (2004) 186-196
36. Zhang Z., Hartmann H., Do V.M., et al. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395 (1998) 698-702